Global Viral Vector & Plasmid DNA Manufacturing Market Report By Product Type (Adenovirus, Lentivirus, Adeno-Associated Virus (AAV), Plasmid DNA, And Others), Application (Gene And Cancer Therapies, Viral Vaccines, Protein Expression Studies, And Others), End User (Hospitals, Biopharmaceutical Companies, Research Institutes, And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2018-2025
ID:VMR11210492
February 2019
Report Formats:

As per this study, the Global Viral Vector & Plasmid DNA Manufacturing Market was valued USD XX.X MN (by revenue) in 2018 and is anticipated to reach USD XX.X MN by 2025 with a CAGR of X.X%.

Viral vector & plasmid DNA manufacturing is a technique to determine the cause of patient’s illness at the molecular level by including the use of system biology and panomics followed by prescribed medicines to address patient’s illness. This technique can reduce the cost of treatment and helps in decreasing further medications. Viral vaccines and gene & cancer therapies are widely used treatments for viral vector & plasmid DNA manufacturing technique.
 
Market Dynamics
 
The rise in the number of gene therapy based programs in the pharmaceutical industry is boosting the global market of viral vector & plasmid DNA manufacturing. Moreover, continuous rise in commercial grade products which can be used for delivering high doses of biopharmaceutical drugs like viral vaccines is further propelling the market growth. However, the high cost of gene therapies can hamper the market of viral vector & plasmid DNA manufacturing.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of viral vector & plasmid DNA manufacturing.
 
Market Segmentation
 
The broad viral vector & plasmid DNA manufacturing market has been sub-grouped into product type, application and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Product Type

  • Adenovirus
  • Lentivirus
  • Adeno-Associated Virus (AAV)
  • Plasmid DNA
  • Others
 
By Application
  • Gene And Cancer Therapies
  • Viral Vaccines
  • Protein Expression Studies
  • Others
 
By End User
  • Hospitals
  • Biopharmaceutical Companies
  • Research Institutes
  • Others.
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for viral vector & plasmid DNA manufacturing in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Viral Vector & Plasmid DNA Manufacturing Market By Revenue (USD MN)
 
Europe Viral Vector & Plasmid DNA Manufacturing Market By Revenue
 
The report also covers a detailed competitive landscape including company profiles of key players operating in the global market. The key players in the viral vector & plasmid DNA manufacturing market include Cobra Biologics, FinVector Vision Therapies, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., General Electric Company (GE Healthcare), Kaneka Corporation (Eurogentec), Lonza, Novasep, Sigma-Aldrich Co. LLC, SIRION Biotech GmbH, VGXI, Inc., VIROVEK. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand. 

1. INTRODUCTION

  • Introduction To Viral Vector & Plasmid DNA Manufacturing
  • Report Description
    • Objectives Of The Study
    • Assumptions
  • Research Scope
  • Research Methodology
    • Data Source
 
2. EXECUTIVE SUMMARY
  • Market Highlight
  • Global Viral Vector & Plasmid DNA Manufacturing Market: Snapshot
 
3. MARKET ANALYSIS
  • Drivers
  • Restraints
  • Opportunities
  • Porter’s Five Forces Analysis
  • Value Chain Analysis
 
4. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET ANALYSIS BY PRODUCT TYPE
  • Viral Vector & Plasmid DNA Manufacturing Market In Adenovirus
  • Viral Vector & Plasmid DNA Manufacturing Market In Lentivirus
  • Viral Vector & Plasmid DNA Manufacturing Market In Adeno-Associated Virus (AAV)
  • Viral Vector & Plasmid DNA Manufacturing Market In Plasmid DNA
  • Viral Vector & Plasmid DNA Manufacturing Market In Others
 
5. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET ANALYSIS BY APPLICATION
  • Viral Vector & Plasmid DNA Manufacturing Market In Gene And Cancer Therapies
  • Viral Vector & Plasmid DNA Manufacturing Market In Viral Vaccines
  • Viral Vector & Plasmid DNA Manufacturing Market In Protein Expression Studies
  • Viral Vector & Plasmid DNA Manufacturing Market In Others
 
6. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET ANALYSIS BY END USER
  • Viral Vector & Plasmid DNA Manufacturing Market In Hospitals
  • Viral Vector & Plasmid DNA Manufacturing Market In Biopharmaceutical Companies
  • Viral Vector & Plasmid DNA Manufacturing Market In Research Institutes
  • Viral Vector & Plasmid DNA Manufacturing Market In Others
 
7. VIRAL VECTOR & PLASMID DNA MANUFACTURING MARKET ANALYSIS BY GEOGRAPHY
  • North America (NA)
    • North America Market Estimates
    • North America Market Estimates By Country
    • United States (U.S.) Market Estimates By Segments
    • Rest Of North America Market Estimates By Segments
  • Europe (EU)
    • Europe Market Estimates
    • Europe Market Estimates By Country
    • United Kingdom (UK) Market Estimates By Segments
    • Germany Market Estimates By Segments
    • France Market Estimates By Segments
    • Rest Of Europe Market Estimates By Segments
  • Asia Pacific (APAC)
    • Asia Pacific Market Estimates
    • Asia Pacific Market Estimates By Country  
    • China Market Estimates By Segments
    • Japan Market Estimates By Segments
    • India Market Estimates By Segments
    • Rest Of Asia Pacific Market Estimates By Segments  
  • Latin America (LA)   
    • Latin America Market Estimates
    • Latin America Market Estimates By Country
    • Brazil Market Estimates By Segments
    • Rest Of Latin America Market Estimates By Segments
  • Middle East And Africa (MEA)   
    • Middle East And Africa Market Estimates
    • Middle East And Africa Market Estimates By Country
    • Middle East Market Estimates By Segments
    • Africa Market Estimates By Segments
 
8. COMPETITIVE LANDSCAPE OF THE VIRAL VECTOR & PLASMID DNA MANUFACTURING COMPANIES
  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments
 
9. COMPANY PROFILES OF THE VIRAL VECTOR & PLASMID DNA MANUFACTURING INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
  • Cobra Biologics
  • FinVector Vision Therapies
  • FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  • General Electric Company (GE Healthcare)
  • Kaneka Corporation (Eurogentec)
  • Lonza
  • Novasep
  • Sigma-Aldrich Co. LLC
  • SIRION Biotech GmbH
  • VGXI, Inc.
  • VIROVEK
 
* Tentative TOC
 
LIST OF TABLES
 
Table 1.  Market Highlights Of Viral Vector & Plasmid DNA Manufacturing
Table 2.  Global Viral Vector & Plasmid DNA Manufacturing Market By Product Type
Table 3.  Global Viral Vector & Plasmid DNA Manufacturing Market By Application
Table 4.  Global Viral Vector & Plasmid DNA Manufacturing Market By End-User
Table 5.  Global Viral Vector & Plasmid DNA Manufacturing Market By Geography
Table 6.  North America Viral Vector & Plasmid DNA Manufacturing Market
Table 7.  Europe Viral Vector & Plasmid DNA Manufacturing Market
Table 8.  Asia Pacific Viral Vector & Plasmid DNA Manufacturing Market
Table 9.  Latin America Viral Vector & Plasmid DNA Manufacturing Market
Table 10. Middle East And Africa Viral Vector & Plasmid DNA Manufacturing Market 
Table 11. Partnership/Collaboration/Agreements
Table 12. Mergers And Acquisitions
Table 13. New Product Development
Table 14. Other Developments
  
LIST OF FIGURES
 
Fig. 1.     Market Segmentation Of Viral Vector & Plasmid DNA Manufacturing Market 
Fig. 2.     Top-Down Approach   
Fig. 3.     Bottom-Up Approach   
Fig. 4.     Market Highlights Of Viral Vector & Plasmid DNA Manufacturing
Fig. 5.     Porter’s Five Forces Analysis
Fig. 6.     Value Chain Analysis
Fig. 7.     Global Viral Vector & Plasmid DNA Manufacturing Market By Product Type
Fig. 8.     Global Viral Vector & Plasmid DNA Manufacturing Market By Application
Fig. 9.     Global Viral Vector & Plasmid DNA Manufacturing Market By End-User
Fig. 10.   Global Viral Vector & Plasmid DNA Manufacturing Market By Geography
Fig. 11.   North America Viral Vector & Plasmid DNA Manufacturing Market
Fig. 12.   Europe Viral Vector & Plasmid DNA Manufacturing Market
Fig. 13.   Asia Pacific Viral Vector & Plasmid DNA Manufacturing Market
Fig. 14.   Latin America Viral Vector & Plasmid DNA Manufacturing Market
Fig. 15.   Middle East And Africa Viral Vector & Plasmid DNA Manufacturing Market
Fig. 16.   Market Share Of Viral Vector & Plasmid DNA Manufacturing Companies
Fig. 17.   Recent Developments In Viral Vector & Plasmid DNA Manufacturing Industry
 
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.  

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials